Abstract
Proteasome inhibitors have a 20-year history in cancer therapy. The first proteasome inhibitor, bortezomib, a breakthrough treatment for multiple myeloma, moved rapidly through development from the bench in 1994 to first FDA approval in 2003. Clinical Cancer Research has chronicled the development of proteasome inhibitors with publication of reports on bortezomib, carfilzomib, and the oral proteasome inhibitor ixazomib (MLN9708).
References
Sep 9, 1994·Cell·V J PalombellaT Maniatis
Nov 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert Z OrlowskiSteven L Soignet
Jun 27, 2003·The New England Journal of Medicine·Paul G RichardsonKenneth C Anderson
Nov 12, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Owen A O'ConnorRobert Z Orlowski
Jul 5, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dharminder ChauhanKenneth C Anderson
Feb 4, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Antonio Garcia-GomezMercedes Garayoa
Citations
Nov 22, 2015·Expert Review of Anticancer Therapy·Massimo OffidaniPietro Leoni
Jul 4, 2015·Expert Opinion on Investigational Drugs·Massimo GentileSilvia Gentili
Mar 26, 2016·BMC Cancer·Jonghoon ParkKwang-Ai Won
Sep 16, 2015·Immunotherapy·Yu-Tzu Tai, Kenneth C Anderson
Jul 23, 2016·Expert Review of Hematology·Rebecca CitrinDavid T Teachey
Jul 14, 2016·Molecular & Cellular Proteomics : MCP·Liang XueRaymond J Deshaies
Jan 5, 2018·Science Translational Medicine·Marsha C Lampi, Cynthia A Reinhart-King
Mar 4, 2018·Cell Death & Disease·Yuan Qing QuRenxiao Wang
Sep 4, 2019·Annual Review of Pharmacology and Toxicology·Lloyd D Fricker
Oct 31, 2017·Calcified Tissue International·Fabrizio AccardiNicola Giuliani
Feb 2, 2019·SLAS Technology·Victor OngEun Ji Chung
Sep 8, 2017·Molecular Cancer Therapeutics·Ronan Le MoigneMark Rolfe
Mar 4, 2021·Journal of Medicinal Chemistry·Rao SongTao Yang
Mar 7, 2021·Biology·Min Seung LeeEui-Ju Yeo
Jun 22, 2021·ACS Pharmacology & Translational Science·Rachel L Mynott, Craig T Wallington-Beddoe